Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bacteriophage therapies re-enter clinical trials.

Literature DB >> 26228748

Bacteriophage therapies re-enter clinical trials.

Katie Kingwell.

Abstract

Entities: Species

Mesh：

Substances：
Anti-Bacterial Agents

Year: 2015 PMID： 26228748 DOI： 10.1038/nrd4695

Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694

Keyword Cloud
Cited

× No keyword cloud information.

18 in total

Review 1. Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection.

Authors: Colleen S Curran; Thomas Bolig; Parizad Torabi-Parizi
Journal: Am J Respir Crit Care Med Date: 2018-03-15 Impact factor: 21.405

Review 2. Microbiome therapeutics - Advances and challenges.

Authors: Mark Mimee; Robert J Citorik; Timothy K Lu
Journal: Adv Drug Deliv Rev Date: 2016-05-05 Impact factor: 15.470

Review 3. Gut Microbiome over a Lifetime and the Association with Hypertension.

Authors: Yuichiro Yano; Teemu J Niiranen
Journal: Curr Hypertens Rep Date: 2021-03-08 Impact factor: 5.369

Review 4. Chronic Rhinosinusitis and the Evolving Understanding of Microbial Ecology in Chronic Inflammatory Mucosal Disease.

Authors: Michael Hoggard; Brett Wagner Mackenzie; Ravi Jain; Michael W Taylor; Kristi Biswas; Richard G Douglas
Journal: Clin Microbiol Rev Date: 2017-01 Impact factor: 26.132

5. Solvent Extraction of Klebsiella pneumoniae Bacteriophage Lysates with 1-Dodecanol Results in Endotoxin Reduction with Low Risk of Solvent Contamination.

Authors: Jordyn Michalik-Provasek; Harley Parker; Lauren Lessor; Jason J Gill
Journal: Phage (New Rochelle) Date: 2021-09-17

10. Dual functionality nanobioconjugates targeting intracellular bacteria in cancer cells with enhanced antimicrobial activity.

Authors: Rohini Singh; Smita Patil; Neetu Singh; Shalini Gupta
Journal: Sci Rep Date: 2017-07-19 Impact factor: 4.379

Bacteriophage therapies re-enter clinical trials.

Review 1. Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection.

Review 2. Microbiome therapeutics - Advances and challenges.

Review 3. Gut Microbiome over a Lifetime and the Association with Hypertension.

Review 4. Chronic Rhinosinusitis and the Evolving Understanding of Microbial Ecology in Chronic Inflammatory Mucosal Disease.

5. Solvent Extraction of Klebsiella pneumoniae Bacteriophage Lysates with 1-Dodecanol Results in Endotoxin Reduction with Low Risk of Solvent Contamination.

6. Isolation and Comparative Genomic Analysis of T1-Like Shigella Bacteriophage pSf-2.

Review 7. Investigational drugs to treat methicillin-resistant Staphylococcus aureus.

Review 8. Adapting Drug Approval Pathways for Bacteriophage-Based Therapeutics.

9. The Lysis of Pathogenic Escherichia coli by Bacteriophages Releases Less Endotoxin Than by β-Lactams.

10. Dual functionality nanobioconjugates targeting intracellular bacteria in cancer cells with enhanced antimicrobial activity.